Here we review the current research involving ROS1-rearranged NSCLC patients, including ROS1 discovery, diagnostics, mechanisms exerted by malignant cells to evade inhibition and strategies to overcome acquired resistance. The gene discussed is ROS1; the disease is non-small cell lung carcinoma.